KBC Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
KBC Group's OCUL Position: Q3 2026 in Review
KBC Group held its Ocular Therapeutix (OCUL) position steady in Q3 2026 at 6,462 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.
KBC Group first reported a position in OCUL in Q4 2025 and has held it in 4 quarters since. The position peaked at $78K in Q4 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- KBC Group held 6,462 shares of Ocular Therapeutix worth $50K as of Q3 2026.
- KBC Group left its Ocular Therapeutix share count unchanged in Q3 2026.
- Ocular Therapeutix made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1719 holding.
- KBC Group first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 4 quarters since.
- KBC Group's Ocular Therapeutix position peaked at $78K in Q4 2025.
- 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.